<h4>Background</h4>Prostate-specific membrane antigen (PSMA) is markedly overexpressed in prostate cancer (PCa), and there is growing evidence to support its usefulness in initial diagnostic assessments. Here, FOLH1 is linked to prostate carcinoma.